KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Leases (2018)

Historic Current Leases for Charles River Laboratories International (CRL) over the last 1 years, with Q4 2018 value amounting to $3.2 million.

Charles River Laboratories International's Current Leases changed N/A to $3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2018, which is N/A changed from last year.
Latest data reveals that Charles River Laboratories International reported Current Leases of $3.2 million as of Q4 2018.
In the past 5 years, Charles River Laboratories International's Current Leases ranged from a high of $3.2 million in Q4 2018 and a low of $3.2 million during Q4 2018